|Registry of biomedical companies:
  [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 496 active entries
1301 Harbor Bay Parkway
Alameda, CA 94502
United States of America, California
Stock symbol: BTX
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
ESI BIO has been built upon a rich legacy of innovation and scientific firsts. We were established in Singapore as ES Cell International in 2000 where we made history by manufacturing the first translatable clinical grade embryonic stem cell lines for distribution to the international research community. The Hyaluronic Acid based hydrogel technology known as HyStem developed by Glycosan BioSystems joined the ESI BIO team. This technology is used extensively in Stem Cell and Oncology research to provide a novel entry to 3D cell culture.
ESI BIO now conducts its operations from multiple locations, including the cities of Alameda CA, La Jolla CA, and Singapore. We are a member of the proud family of stem-cell-based subsidiary companies owned by BioTime, Inc., from which we benefit from a deep source of excellent science, intellectual property and stem cell technologies. We emphasize collaboration with our customers as a cornerstone of our strategy and we encourage individuality and autonomy among our staff to nurture creativity.
Last update of this entry: January 13, 2015